Early immunologic response to mRNA COVID-19 vaccine in patients receiving biologics and/or immunomodulators

Patients with immune conditions and immune-modifying therapies were excluded from the Covid-19 vaccine trials. Studies have shown conflicting response to different vaccines in persons receiving immune suppressors or biologics. The aim of this study is to evaluate humoral and cellular response to Cov...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Martinó, Esteban, Medina-Prieto, Rafael, Santana-Bagur, Jorge, Santé, María, Pantoja, Petraleigh, Espino, Ana M., Sariol, Carlos A., Torres, Esther A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452103/
https://www.ncbi.nlm.nih.gov/pubmed/34545370
http://dx.doi.org/10.1101/2021.09.11.21263211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452103/
https://www.ncbi.nlm.nih.gov/pubmed/34545370
http://dx.doi.org/10.1101/2021.09.11.21263211

Ejemplares similares